Fundamental analysis · SEC EDGAR · TTM through 28/03/2026

Fundamental analysis of Thermo Fisher Scientific Inc.

TMO · NYSE · Measuring & Controlling Devices, NEC

Fundamental quality

DEMANDING

53

out of 100

Breakdown by area

I.GrowthEPS: 1% · Revenue: 0.2%
30
II.ProfitabilityNet margin: 15.2% · ROE: 13.2%
73
III.Financial healthNet debt/EBITDA: 4.77x · FCF: 14.9%
56

Source: SEC EDGAR · TTM through 28/03/2026

Reading the numbers

On average over recent years, earnings per share grew 1% a year and revenue advanced 0.2% a year.

On profitability, Thermo Fisher Scientific Inc. shows a net margin of 15.2%, an ROE of 13.2%.

Its financial health shows net debt of 4.77 times its EBITDA and a free cash flow margin of 14.9%.

Adding up growth, profitability and financial strength, the traffic light gives TMO a fundamental quality of 53 out of 100. To also know whether it's cheap or expensive, the price is missing: enter it in the tool and you'll get the valuation verdict (P/E against its sector).

The thresholds are general and the system doesn't judge qualitative factors. See the full methodology and use this analysis as a first filter, never as a final decision.

Is Thermo Fisher Scientific Inc. cheap or expensive?

That depends on the current price. Look it up, enter it in the tool and get the full valuation verdict (P/E against its sector).

Compute the valuation →
Advertising

Where to buy Thermo Fisher Scientific Inc.?

Brokers you can use to invest in U.S. and European stocks.

Compare the brokers →